Trial Profile
Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expiration flow of NO). A single-centre, placebo controlled, randomized, double blind, cross-over study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2019
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salbutamol
- Indications Asthma
- Focus Biomarker; Therapeutic Use
- Acronyms FENOMENO
- Sponsors Chiesi Farmaceutici
- 24 Sep 2019 This trial has been discontinued in United kingdom
- 23 Jul 2011 New trial record